The PI3K inhibitor buparlisib suppresses osteoclast formation and tumour cell growth in bone metastasis of lung cancer, as evidenced by multimodality molecular imaging

Shengfei Wang(Fudan University Shanghai Cancer Center), Jie Zhang(Xi'an Jiaotong University)
Oncology Reports
March 20, 2019
Cited by 17


Related Papers